Skip to content

News

전체게시글 61
  • [Tech Dogs] Kine Sciences Announces First Patient Dosed In The Phase 1B/2A Study In Patients With Chronic Inflammatory Demyelin
    출처 : Kine Sciences Announces First Patient Dosed In The Phase 1B/2A Study In Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - TechDogs
    작성일
    2024.09.25
  • [Rare Disease ADVISOR] First Patient Dosed in Trial of KINE-101 for CIDP
    출처 : First Patient Dosed in Trial of KINE-101 for CIDP (rarediseaseadvisor.com)
    작성일
    2024.09.25
  • [Clinical Trials Arena] Kine Sciences doses first subject in Phase Ib/IIa CIDP treatment trial
    출처 : Kine Sciences doses first subject in CIDP treatment trial (clinicaltrialsarena.com)
    작성일
    2024.09.25
  • [NeurologyLive] Dosing Underway for Phase 1b/2a Trial of KINE-101 in Chronic Inflammatory Demyelinating Polyneuropathy
      출처 : NeurologyLive -  Dosing Underway for Phase 1b/2a Trial of KINE-101 in Chronic Inflammatory Demyelinating Polyneuropathy
    작성일
    2024.09.24
  • [메디칼타임즈] 카인사이언스, 국내 임상시험 첫 환자 등록 성공
      메디칼타임즈 - 카인사이언스, 국내 임상시험 첫 환자 등록 성공
    작성일
    2024.09.23
  • 처음
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
  • 마지막

© 2025 IR